Cite
HARVARD Citation
Kikuchi, A. et al. (2017). ASP5878, a selective FGFR inhibitor, to treat FGFR3‐dependent urothelial cancer with or without chemoresistance. Cancer science. 108 (2), pp. 236-242. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kikuchi, A. et al. (2017). ASP5878, a selective FGFR inhibitor, to treat FGFR3‐dependent urothelial cancer with or without chemoresistance. Cancer science. 108 (2), pp. 236-242. [Online].